Adverse drug event reporting system to be streamlined

The Korea Food and Drug Administration (KFDA) said last Friday that all of adverse drug events (ADEs), including the ones reported during the drug re-examination period, will be solely handled by the Korea Institute of Drug Safety & Risk Management (KIDS) as part of efforts to streamline the nation’s ADE reporting system.

Under the revised regulation, the KIDS systematically collects adverse...